Skip to main content
AMPLITUDE-O: Efpeglenatide benefits in high-risk diabetes
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
AMPLITUDE-O: Efpeglenatide benefits in high-risk diabetes
User login
Username
Password
Reset your password
Concept
Lead
score
Type 2 Diabetes Mellitus
1
1
GLP-1 Receptor Agonist
0
0.9
V-Series Nerve Agent
0
0.62
Receptors
0
0.44
Renal Disease
0
0.44
Cardiovascular Risk Management
0
0.8
Meta-Analysis
0
0.31
Heart Failure (HF)
0
0.21
Acute Coronary Syndrome
0
0.14
Cerebrovascular Accident
0
0.14
Cardiovascular disease
0
0.13
Angina Pectoris
0
0.12
Hemoglobin A1c
0
0.09
Constipation
0
0.07
Diarrhea
0
0.07
Myocardial Infarction (MI)
0
0.07
Patient Safety
0
0.07
Retinal Diseases
0
0.07
Abdominal Bloating
0
0.06
Adverse Effects
0
0.06
Dorsum
0
0.06
Emesis
0
0.06
Health Policy
0
0.06
Heart
0
0.06
Hemoglobin
0
0.06
Hypoglycemia
0
0.06
Infarction
0
0.06
Nausea
0
0.06
Quality of Life
0
0.06
Retinopathy
0
0.06
SGLT2 Inhibitor
0
0.06
Unstable Angina
0
0.06
Specialty
Lead
score
Diabetes & Endocrinology
1
1
Internal Medicine
0
0.8
Cardiology
0
0.9